DOSTINEX Israel - English - Ministry of Health

dostinex

pfizer pfe pharmaceuticals israel ltd - cabergoline - tablets - cabergoline 0.5 mg - cabergoline - cabergoline - treatment of hyperprolactinemic disorders.dostinex is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. dostinex is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .